P-selectin expression in chronic allergic airway inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 271s Year: 2001
P-selectin glycoprotein ligand-1 expression on leukocytes from patients with allergic asthma, COPD, and smokers Source: Eur Respir J 2004; 24: Suppl. 48, 453s Year: 2004
Effects of platelet-activating factor (PAF) challenge on airway neutrophilia and adhesion molecules in mild asthma Source: Eur Respir J 2001; 18: Suppl. 33, 163s Year: 2001
Eosinophilopoietins receptors, TGF-ß1 and outer-membrane integrins expression of lung-resident and inflammatory eosinophils in severe non-allergic eosinophilic asthma Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma Year: 2019
CCR4 ligands are up-regulated in the airways of atopic asthmatics after segmental allergen challenge Source: Eur Respir J 2004; 23: 876-884 Year: 2004
The CC chemokine receptors CCR1 and CCR4 are expressed on airway mast cells in allergic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 106s Year: 2005
Inhibition of the asthmatic allergen challenge response by the CRTH2 antagonist OC000459 Source: Eur Respir J 2013; 41: 46-52 Year: 2013
Chemokine and cytokine production in the airway from atopic asthmatics after segmental allergen challenge Source: Eur Respir J 2003; 22: Suppl. 45, 378s Year: 2003
Role of CCL21 and CCL19 in allergic inflammation examined by murine asthmatic model Source: Annual Congress 2006 - Immunology of the airways Year: 2006
Aspirin enhances the CD11b expression of eosinophils in patients with aspirin-intolerance asthma Source: Eur Respir J 2003; 22: Suppl. 45, 572s Year: 2003
High-level expression of PD-L1 by DC suppresses airway inflammation in OVA-induced allergic asthma Source: Annual Congress 2010 - Animal models of asthma and lung inflammation Year: 2010
Chemokines receptors expression in induced sputum in COPD and asthma Source: Annual Congress 2003 - Activation, migration and death of immune cells Year: 2003
Neutrophils and neutrophil chemokine receptor (CXCR1 and 2) gene expression in severe exacerbations of COPD and asthma Source: Eur Respir J 2001; 18: Suppl. 33, 501s Year: 2001
Neutrophil airway influx by platelet-activating factor in asthma: role of adhesion molecules and LTB4 expression Source: Eur Respir J 2003; 22: 290-297 Year: 2003
Omalizumab protects against allergen-induced bronchoconstriction in patients with allergic (IgE-mediated) asthma and high baseline IgE levels Source: Annual Congress 2009 - Severe asthma and its treatment Year: 2009
The PAR2 -activating peptide SLIGRL inhibits airway hyper-responsiveness and eosinophilia in an acute murine model of allergic asthma Source: Annual Congress 2004 - Animal models of asthma and chronic bronchitis and their relevance in pulmonary pharmacology Year: 2004
T-cell co-stimulatory molecules: their role in allergic immune reactions Source: Eur Respir J 2007; 29: 1246-1255 Year: 2007
Rhinovirus-induced cytokine production of circulating leukocytes is reduced in severe asthma Source: Virtual Congress 2020 – New insight into the immunology of asthma and COPD Year: 2020
The effect of a leukotriene antagonist, pranlukast, on allergen-induced airway responses and circulating dendritic cells in subjects with atopic asthma Source: Eur Respir J 2003; 22: Suppl. 45, 414s Year: 2003
Induced sputum levels of soluble receptor ST-2 in adult patients suffering from allergic asthma or allergic rhinitis Source: International Congress 2016 – Laboratory tests and cell biology in allergy and immunology Year: 2016